Image

2023 HFSA Annual Scientific Meeting OnDemand

Educational Activity

The 2023 HFSA Annual Scientific Meeting OnDemand contains recordings of scientific sessions held during the HFSA Annual Scientific Meeting 2023. Learners can view recorded presentations to enhance their knowledge and learn the latest in heart failure care, treatment, research, and more. Continuing education credits are available for this product.

 

This educational activity is designed for HFSA’s Annual Scientific Meeting is intended for physicians, nurses, nurse practitioners, pharmacists, scientists, and health care professionals who specialize or have an interest in heart failure.

 

Original recording Date: October 6-9, 2023

Expiration Date: November 19, 2024

 

Member's Rate: $499/Non-Member's Rate: $599

 

Educational Content included in the Annual Scientific Meeting OnDemand

 

1st Annual HFSA Case Competition

 

Advances in Cardio-Oncology

 

Approach to Suspected HFpEF Evaluation in 2023

 

Artificial Intelligence & Machine

Learning: The Future is Now or Later?

 

Cardiogenic Shock Management

 

Caring for the Pregnant Patient with Heart Failure

 

Challenges in Diagnosis and

Management of Cardiac Amyloidosis

 

Contemporary Management of Cardiac Sarcoidosis

 

Current Electrophysiology Perspectives in LVAD Patients

 

Device Innovation to Manage Congestion in Heart Failure

 

 

 

 

Electrophysiology Considerations in Heart Failure

 

Engaging Cardiovascular Team Clinicians in Clinical Trial Research and Quality Improvement

 

FDA Special Session: Subgroups and Subpopulations in HF Clinical Trials

 

Frontiers in Surveillance of the Transplanted Heart: What Lies Beneath

 

Great Debates in Heart Failure

 

Heart Failure Editor’s Forum: Journal Visions, Multi-Disciplinary Efforts, Top Science and Role in Increasing HF Clinicians

 

HFpEF Mechanisms of Disease: New Insights and Therapeutic Implications

 

HFSA Spotlight: Rapid Fire Abstracts: Emerging Heart Failure Therapies

 

Hot Topics in HF: Management of Anemia and Iron Deficiency

 

Jay N. Cohn (JNC) New Investigator Award Presentations

 

 

Managing Congestion: Targeting Pressure vs Volume

 

Monday Plenary Session: HFSA Spotlight on Featured Clinical Science

 

New Paradigms of Care in Hypertrophic Cardiomyopathy

 

Novel Implementation Strategies and How-to

 

Nursing New Investigator Award

 

Practical Implementation of Guideline-Directed Medical Therapy in Heart Failure

 

Presidential Plenary Session

 

Pulmonary Hypertension and RV Failure in Advanced Heart Failure

 

Remote Care in Heart Failure Post Pandemic

 

Structural Interventions for Heart Failure: Challenges and Controversies

 

 

 

 

 

 

 

Sunday Plenary Session: HFSA Spotlight on Late Breaking ClinicalTrials

 

Targeting Obesity to Treat Heart Failure

 

The Future of the Machines

 

The Heart Allocation System in the United States

 

The Importance of Implementation

 

The State of the Specialty Town Hall

 

Value Based Payment & the Business of Heart Failure

 

What You Need to Know in 30 Minutes: Frailty Assessment and Cardiac Rehabilitation in Patients with HF

 

What You Need to Know in 30 Minutes: Sleep Apnea in Heart Failure

 

What You Need to Know in 30 Minutes: Urine Sodium to Manage Acute Heart Failure

 

 

 

 

Following this educational activity, attendees will be able to:

 

  • Describe the epidemiology of HF and implement strategies for the prevention of HF.
  • Discuss the current scientific basis of HF from the perspectives of cardiovascular physiology, neurohormones, tissue factors, molecular biology, and genetics.
  • Identify the findings of basic science research and current clinical trials and describe their implications for current and future HF therapy.
  • Implement optimal guideline-based therapeutic options for HF, including pharmacologic agents, non-pharmacologic options, such as diet and exercise, and implantable devices.
  • Manage comorbidities including hypertension, diabetes, depression, sleep apnea, and chemotherapy.
  • Demonstrate awareness of psychosocial, economic, regulatory, and ethical issues in the treatment of patients with HF.
    Explain the patient, provider and system-related factors that contribute to racial and ethnic health disparities.
  • Implement strategies for effective management of the patient with HF, incorporating the family, encouraging self- care, and employing the team approach.
  • Outline strategies for transitioning patients from impatient to outpatient care and for reducing hospital readmissions.
  • Engage in performance measurement and other site-based research.

 

 

LO_Icon

Credits Available

CME 47.25; CNE:47.25 (including nursing pharmacology of 13.00)

CPE: 27.5

MOC: 7.75

Powered by Oasis.